1-(4-Bromo-3-methylphenyl)dihydropyrimidine-2,4(1H,3H)-dione

Catalog No. :
ACDIAB466
CAS No. :
1542076-40-3
Molecular Formula :
C11H11BrN2O2
Molecular Weight :
283.13

IUPAC Name:1-(4-bromo-3-methylphenyl)dihydropyrimidine-2,4(1H,3H)-dione

1-(4-Bromo-3-methylphenyl)dihydropyrimidine-2,4(1H,3H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$84.00Login to see priceIn stockInquiry
1g95%$221.00Login to see priceIn stockIn stock
5g95%$735.00Login to see priceIn stockIn stock
10g95%$1177.00Login to see priceIn stockIn stock
25g95%$2648.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Bromo-3-methylphenyl)dihydropyrimidine-2,4(1H,3H)-dione
IUPAC Name1-(4-bromo-3-methylphenyl)dihydropyrimidine-2,4(1H,3H)-dione
MDL No.0
Molecular FormulaC11H11BrN2O2
Molecular Weight283.13
SMILESO=C1NC(CCN1C2=CC=C(Br)C(C)=C2)=O
InChI KeyIEDRIIIXHVSPOD-UHFFFAOYSA-N
Synonym1-(4-Bromo-3-methylphenyl)dihydro-2,4(1H,3H)-pyrimidinedione;1-(4-bromo-3-methylphenyl)-1,3-diazinane-2,4-dione;1-(4-Bromo-3-methylphenyl)dihydropyrimidine-2,4(1H,3H)-dione
CAS No.1542076-40-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACDIAB466 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDIAB466 route product structure diagram
    ACDIAB4661542076-40-3 In Stock
Inquiry

2. ACDIAB466 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDIAB466 route product structure diagram
    ACDIAB4661542076-40-3 In Stock
Inquiry

Comments (0)